CDMO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CDMO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Avid Bioservices's yield on cost for the quarter that ended in Oct. 2024 was 0.00.
The historical rank and industry rank for Avid Bioservices's 5-Year Yield-on-Cost % or its related term are showing as below:
For the Biotechnology subindustry, Avid Bioservices's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Avid Bioservices's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Avid Bioservices's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Avid Bioservices is calculated as
Yield-on-Cost | = | Dividend Yield % | * | (1 | + | Dividend Growth Rate)^5 |
Avid Bioservices (NAS:CDMO) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Thank you for viewing the detailed overview of Avid Bioservices's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.
Richard A. Richieri | officer: Chief Operations Officer | 14191 MYFORD ROAD, TUSTIN CA 92780 |
Matthew R. Kwietniak | officer: Chief Commercial Officer | 14191 MYFORD ROAD, TUSTIN CA 92780 |
Nicholas Stewart Green | director, officer: President & CEO | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Daniel Ryan Hart | officer: Chief Financial Officer | 2642 MICHELLE DR., SUITE 200, TUSTIN CA 62780 |
Mark R Ziebell | officer: V.P., General Counsel | 14282 FRANKLIN AVENUE, TUSTIN CA 92780 |
Richard B Hancock | director | 14282 FRANKLIN AVE., TUSTIN CA 92780 |
Joseph Carleone | director | 3883 HOWARD HUGHES PKWY, SUITE 700, LAS VEGAS NV 89169 |
Gregory Sargen | director | |
Esther M. Alegria | director | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
Mark R Bamforth | director | 500 KENDALL ST., CAMBRIDGE MA 02142 |
Jeanne Thoma | director | C/O ANI PHARMACEUTICALS, INC., 210 MAIN STREET WEST, BAUDETTE MN 56623 |
Patrick D Walsh | director | 14282 FRANKLIN AVE., TUSTIN CA 92780 |
Catherine J Mackey | director | 3595 JOHN HOPKINS COURT, SAN DIEGO CA 92121 |
Joel Mccomb | director | 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121 |
Stephen Michael Hedberg | officer: Principal Fin. & Acct. Officer | 2642 MICHELLE DRIVE, SUITE 200, TUSTIN CA 92780 |
From GuruFocus
By Marketwired • 11-08-2024
By GuruFocus News • 12-13-2024
By Marketwired • 02-05-2025
By Marketwired • 02-05-2025
By Marketwired • 01-21-2025
By Marketwired • 12-30-2024
By Marketwired • 11-07-2024
By Marketwired • 12-04-2024
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.